Cue Biopharma, Inc.
CUEFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Cue Biopharma, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 8, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 213,828 | Not shown | SEC filing |
| ARMSTRONG ADVISORY GROUP, INC | 2026-03-31 | 120 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 449,161 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 415 | Not shown | SEC filing |
| Visionary Wealth Advisors | 2026-03-31 | 29,285 | Not shown | SEC filing |
| Texas Capital Bank Wealth Management Services Inc | 2026-03-31 | 397,421 | Not shown | SEC filing |
| SIMPLEX TRADING, LLC | 2026-03-31 | 875 | Not shown | SEC filing |
| GC Wealth Management RIA, LLC | 2026-03-31 | 4,631,644 | Not shown | SEC filing |
| Virtu Financial LLC | 2026-03-31 | 49,553 | Not shown | SEC filing |
| Dauntless Investment Group, LLC | 2026-03-31 | 2,416 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 179,353 | Not shown | SEC filing |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC | 2026-03-31 | 18,987 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 34,151 | Not shown | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 300 | Not shown | SEC filing |
| MATHER GROUP, LLC. | 2026-03-31 | 1,000 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 24,614 | Not shown | SEC filing |
| STIFEL FINANCIAL CORP | 2026-03-31 | 246,556 | Not shown | SEC filing |
| NFSG Corp | 2026-03-31 | 3,000 | Not shown | SEC filing |
| SeaCrest Wealth Management, LLC | 2026-03-31 | 10,000 | Not shown | SEC filing |
- Each value is checked against Cue Biopharma, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 19 rows: no share price from within three months of their report dates is on file, so they could not be checked.
- 1 row left out: the value per share it reports is far from Cue Biopharma, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- SeaCrest Wealth Management, LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- NFSG Corp: 3,000 shares reported 2025-12-31; 3,000 shares reported 2026-03-31.
- STIFEL FINANCIAL CORP: 246,556 shares reported 2025-12-31; 246,556 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 168,829 shares reported 2025-12-31; 24,614 shares reported 2026-03-31.
- OSAIC HOLDINGS, INC.: 680 shares reported 2025-12-31; 300 shares reported 2026-03-31.
- PREVAIL INNOVATIVE WEALTH ADVISORS, LLC: 18,987 shares reported 2025-12-31; 18,987 shares reported 2026-03-31.
- STATE STREET CORP: 179,353 shares reported 2025-12-31; 179,353 shares reported 2026-03-31.
- GC Wealth Management RIA, LLC: 4,631,644 shares reported 2025-12-31; 4,631,644 shares reported 2026-03-31.
- SIMPLEX TRADING, LLC: 2,557 shares reported 2025-12-31; 875 shares reported 2026-03-31.
- Texas Capital Bank Wealth Management Services Inc: 440,670 shares reported 2025-12-31; 397,421 shares reported 2026-03-31.
- BNP PARIBAS FINANCIAL MARKETS: 415 shares reported 2025-12-31; 415 shares reported 2026-03-31.
- BlackRock, Inc.: 449,162 shares reported 2025-12-31; 449,161 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
19 filers have only one report here.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-01 | Lin Shao-Lee · Chief Executive Officer | Common Stock Warrants (Right to Buy) | P — Open market or private purchase | +45,453 | unknown | SEC filing |
| 2026-06-01 | Lin Shao-Lee · Chief Executive Officer | Pre-Funded Warrants (Right to Buy) | P — Open market or private purchase | +90,906 | 11.00 | SEC filing |
| 2025-12-30 | Sarraf Pasha · Director | Common Stock | P — Open market or private purchase | +77,148 | 0.30 | SEC filing |
| 2025-12-30 | Sarraf Pasha · Director | Common Stock | P — Open market or private purchase | +86,947 | 0.32 | SEC filing |
| 2025-12-30 | Sarraf Pasha · Director | Common Stock | P — Open market or private purchase | +4,229 | 0.31 | SEC filing |
| 2025-12-30 | Sarraf Pasha · Director | Common Stock | P — Open market or private purchase | +78,116 | 0.31 | SEC filing |
| 2025-12-30 | Sarraf Pasha · Director | Common Stock | P — Open market or private purchase | +77,417 | 0.30 | SEC filing |
| 2024-12-16 | PASSERI DANIEL R · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +30,000 | 1.03 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-30 | Camardo Daniel A. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +1,626 | SEC filing |
| 2026-05-30 | Meehan Viola Mong · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +1,626 | SEC filing |
| 2026-05-03 | Lin Shao-Lee · CHIEF EXECUTIVE OFFICER | Stock Option (right to buy) | A — Grant, award, or other acquisition | +655,074 | SEC filing |
| 2026-05-03 | Lin Shao-Lee · CHIEF EXECUTIVE OFFICER | Common Stock | A — Grant, award, or other acquisition | +327,537 | SEC filing |
| 2026-04-09 | Sandercock Colin · SVP, GENERAL COUNSEL | Stock Option (right to buy) | A — Grant, award, or other acquisition | +200,000 | SEC filing |
| 2026-04-09 | Warren Lucinda · CHIEF BUSINESS OFFICER | Stock Option (right to buy) | A — Grant, award, or other acquisition | +250,000 | SEC filing |
| 2026-04-09 | Baker Daniel G. · CHIEF DEVELOPMENT OFFICER | Stock Option (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-01-02 | Broadfoot Jill Marie · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +24,400 | SEC filing |
Showing 8 of 34 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2019-12-12 | MARLETT CHRISTOPHER A · Director | Common Stock | J — Other acquisition or disposition | −1,007,973 | SEC filing |
| 2019-12-12 | MARLETT CHRISTOPHER A · Director | Common Stock | J — Other acquisition or disposition | +755,980 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.